SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-050851
Filing Date
2020-11-05
Accepted
2020-11-05 07:05:59
Documents
14
Period of Report
2020-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K stro-8k_20201105.htm   iXBRL 8-K 36089
2 EX-99.1 stro-ex991_6.htm EX-99.1 222449
3 GRAPHIC g3cd0or0bops000001.jpg GRAPHIC 3311
  Complete submission text file 0001564590-20-050851.txt   412857

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA stro-20201105.xsd EX-101.SCH 5776
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE stro-20201105_lab.xml EX-101.LAB 20223
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stro-20201105_pre.xml EX-101.PRE 12086
7 EXTRACTED XBRL INSTANCE DOCUMENT stro-8k_20201105_htm.xml XML 3679
Mailing Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080
Business Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38662 | Film No.: 201288626
SIC: 2836 Biological Products, (No Diagnostic Substances)